Andrisani, Gianluca
 Distribuzione geografica
Continente #
EU - Europa 835
NA - Nord America 762
AS - Asia 157
AF - Africa 2
Totale 1.756
Nazione #
US - Stati Uniti d'America 760
DE - Germania 430
CN - Cina 96
SE - Svezia 94
UA - Ucraina 90
IT - Italia 63
FR - Francia 48
GB - Regno Unito 45
IE - Irlanda 28
IN - India 23
FI - Finlandia 18
SG - Singapore 18
TR - Turchia 10
BE - Belgio 5
IR - Iran 4
JP - Giappone 3
PL - Polonia 3
RU - Federazione Russa 3
BG - Bulgaria 2
CA - Canada 2
CI - Costa d'Avorio 2
GR - Grecia 2
NL - Olanda 2
TW - Taiwan 2
CH - Svizzera 1
GE - Georgia 1
HU - Ungheria 1
Totale 1.756
Città #
Chandler 172
Jacksonville 76
Ashburn 57
San Mateo 51
Dearborn 43
Ann Arbor 34
Cattolica 32
New York 32
Dublin 28
Nürnberg 24
Nanjing 23
Munich 20
Milan 17
Wilmington 17
Lawrence 15
Houston 14
Lancaster 14
Beijing 13
Boston 13
Bremen 12
Singapore 11
Izmir 10
Leawood 8
Seattle 8
Shenyang 8
Woodbridge 8
Brussels 5
Fairfield 5
Mountain View 5
Nanchang 5
Ardabil 4
Hebei 4
Jiaxing 4
Marseille 4
Augusta 3
Changsha 3
Costa Mesa 3
Detroit 3
Edinburgh 3
Kraków 3
Los Angeles 3
Redwood City 3
Shanghai 3
Simi Valley 3
University Park 3
Washington 3
Abidjan 2
Berlin 2
Boardman 2
Changchun 2
Corsico 2
Fremont 2
Guangzhou 2
Hangzhou 2
Hefei 2
Kunming 2
London 2
Millbury 2
Moscow 2
Norwalk 2
Princeton 2
Rome 2
Sofia 2
Taipei 2
Tianjin 2
Ahmedabad 1
Amsterdam 1
Andover 1
Athens 1
Bern 1
Budapest 1
Clearwater 1
Delhi 1
Fuzhou 1
Ipswich 1
Kyiv 1
Landshut 1
Monmouth Junction 1
Montreal 1
Montréal 1
Novara 1
Ocean Grove 1
Paris 1
Pisa 1
Pittsburgh 1
Pune 1
Quzhou 1
Raritan 1
Redmond 1
Ribera 1
San Jose 1
Shaoxing 1
Tappahannock 1
Tbilisi 1
Tettnang 1
Wuhan 1
Zhengzhou 1
Totale 902
Nome #
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 149
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 139
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 139
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 133
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 132
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 130
Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab 117
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 115
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 109
Use of infliximab in particular clinical settings: management based on current evidence. 95
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery 87
Giant arteriovenous malformation of the colon mimicking lipoma 79
Management of perianal fistulas in Crohn's disease: an up-to-date review 71
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 71
AID in aging and autoimmune diseases 67
Mucosal healing in ulcerative colitis: surveillance or colectomy? 67
Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease. 63
Totale 1.763
Categoria #
all - tutte 5.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.109


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020301 50 12 38 12 24 46 23 13 20 8 33 22
2020/2021152 2 19 3 19 19 3 17 9 22 1 34 4
2021/2022194 20 18 4 41 3 1 2 44 4 1 19 37
2022/2023387 52 53 21 78 33 45 8 26 53 2 10 6
2023/2024164 8 44 5 12 3 32 5 16 2 5 15 17
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.763